Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02632045
Title Study of Efficacy of Ribociclib After Progression on CDK4/6 Inhibition in Patients With HR+ HER2- Advanced Breast Cancer (MAINTAIN)
Acronym MAINTAIN
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Melissa K Accordino
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham (UAB) Birmingham Alabama 35294 United States Details
Northside Hospital, Inc. Atlanta Georgia 30342 United States Details
Northwestern Medical Hospital Chicago Illinois 60611 United States Details
The University of Kansas Cancer Center Westwood Kansas 66205 United States Details
Albert Einstein University / Montefiore Medical Center Bronx New York 10461 United States Details
Northwell Health/Monter Cancer Center Lake Success New York 11042 United States Details
NYU Langone Medical Center New York New York 10016 United States Details
Mount Sinai Medical Center New York New York 10029 United States Details
Columbia University Medical Center New York New York 10032 United States Details
Weill Cornell Medical Center New York New York 10065 United States Details
Stony Brook Cancer Center Stony Brook New York 11794 United States Details
Vanderbilt-Ingham Cancer Center Nashville Tennessee 37232 United States Details
University of Wisconsin School of Medicine Madison Wisconsin 53792-001 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field